Praemonitus praemunitus: can we forecast and prepare for future viral disease outbreaks?

Muratov, Eugene

doi:10.22541/au.166490960.04750244/v1

2022

DOI: 10.22541/au.166490960.04750244/v1

|View full text |Cite

Preprint

Praemonitus praemunitus: can we forecast and prepare for future viral disease outbreaks?

Eugene Muratov¹

Abstract: While future viral outbreaks are unavoidable, we should be able to forecast the time and location of the outbreaks and minimize their potential impacts through consistently funded research in the fields of virology and antiviral drug discovery.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 77 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Favipiravir: An Effective Rna Polymerase Modulating Anti-Influenza Drug

Yash,

Sarika,

Laxmikant

2023

Biosci., Biotech. Res. Asia

View full text Add to dashboard Cite

Combination of all the aspects are covered in this review from anti-influenza drug.Several articles neglected to include a point of view. The majority of review papers emphasiseon epidemiology. In order to lessen the financial burden of disease and its negative effects, it is important to raise awareness about disease and how to manage it.The medicine favipiravir,additionally called T-705 (5-fluro-2-oxo-1H-pyrazine-3-carboxamide), by selection and powerfully inhibits the polymer-dependent polymer accelerator (RdRp) of polymer viruses. Favipiravir was discovred by the company Toyama Chemical Co., Ltd.By searching a chemical library for the respiratory illness virus's antiviral properties. Favipiravir-RTP (favipiravir ribofuranosyl-5′-triphosphate), the active version of the drug, is recognised by RdRpas a substrate and restrains the polymer accelerator's activityFavipiravir is efficient against a broad kind of subtypes and variations of respiratory disorder viruses.

show abstract

Favipiravir: An Effective Rna Polymerase Modulating Anti-Influenza Drug

Yash,

Sarika,

Laxmikant

2023

Biosci., Biotech. Res. Asia

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Praemonitus praemunitus: can we forecast and prepare for future viral disease outbreaks?

Abstract: While future viral outbreaks are unavoidable, we should be able to forecast the time and location of the outbreaks and minimize their potential impacts through consistently funded research in the fields of virology and antiviral drug discovery.

Cited by 1 publication

References 77 publications

Favipiravir: An Effective Rna Polymerase Modulating Anti-Influenza Drug

Favipiravir: An Effective Rna Polymerase Modulating Anti-Influenza Drug

Contact Info

Product

Resources

About